Примери за използване на Infusion should be stopped на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
The infusion should be stopped if these reactions occur.
If extravasation occurs, infusion should be stopped immediately.
If during the first infusion, an infusion-related reaction occurs within the first 15 minutes, the infusion should be stopped.
In the event of a hypoglycaemic episode, the infusion should be stopped until the episode is resolved.
The infusion should be stopped once the radioactivity emission from the vial becomes stable for several minutes(or during two consecutive measurements).
If allergic or anaphylactic reactions occur,the injection/infusion should be stopped immediately.
If a reaction occurs, the infusion should be stopped and patients should receive appropriate treatment.
If the blood pressure orheart rate suddenly decreases the infusion should be stopped immediately.
If these reactions occur, the Aldurazyme infusion should be stopped immediately and appropriate treatment will be started by your doctor.
If such signs develop, with orwithout symptomatic hypotension or bradycardia, the infusion should be stopped immediately.
For severe infusion reactions, infusion should be stopped and pembrolizumab permanently discontinued(see section 4.2).
If the confirmed aPTT value is above the target range, the infusion should be stopped for two hours.
In case of a single severe IAR, the infusion should be stopped until the symptoms are resolved and treatment with antihistamines and paracetamol should be considered.
If the level of prothrombin is lowered,then the intake of infusion should be stopped- the result is achieved.
In case of a single severe IAR, the infusion should be stopped until the symptoms are resolved and treatment with antihistamines and paracetamol/ ibuprofen should be considered.
Use aseptic technique when inserting the infusion set.• In the event of a hypoglycaemic episode, the infusion should be stopped until the episode is resolved.
The infusion should be stopped and cemiplimab should be permanently discontinued for severe(Grade 3) or life-threatening(Grade 4) infusion-related reactions(see section 4.2).
In the event of a hypoglycaemic episode, the infusion should be stopped until the episode is resolved.
INTEGRILIN infusion should be stopped immediately if circumstances arise that necessitate thrombolytic therapy or if the patient must undergo an emergency CABG surgery or requires an intraortic balloon pump.
If allergic or anaphylactic reactions occur,the injection/ infusion should be stopped immediately and patients should contact their physician.
If you have any side effects that might be related to the administration of Voncento,the injection or infusion should be stopped(see also section 2).
For Grade 3 or Grade 4 infusion-related reactions, the infusion should be stopped and avelumab should be permanently discontinued(see section 4.2).
If serious bleeding occurs that is not controllable with pressure, the INTEGRILIN infusion should be stopped immediately and any unfractionated heparin that is given concomitantly.
If allergic reactions occur during injection or infusion, administration should be stopped immediately.
In patients whose blood magnesium levels are elevated orsigns of hypermagnesaemia are identified Numeta G16%E should be stopped or the infusion rate reduced.
Administration of the medicinal product which caused displacement should be stopped in case of an infusion.
If serum magnesium levels are elevated the infusion of Numeta G16%E should be stopped or infusion rate reduced as deemed clinically appropriate and safe.
If serum magnesium levels are elevated(above reference range normal values) the infusion of< Invented Name> should be stopped or infusion rate reduced as deemed clinically appropriate and safe.
Monoclonal antibodies can penetrate into the mother's milk andhave undesirable effects on the newborn's body, so breastfeeding during the treatment period should be stopped, resuming no earlier than 6 months after the last infusion. .
Monoclonal antibodies can penetrate into breast milk and have undesirable effects on the body of the newborn, andtherefore breastfeeding during the period of treatment should be stopped, restarting no earlier than 6 months after the last infusion. .